PHENAZINE-35 Drug Patent Profile
✉ Email this page to a colleague
When do Phenazine-35 patents expire, and when can generic versions of Phenazine-35 launch?
Phenazine-35 is a drug marketed by Abc Holding and is included in one NDA.
The generic ingredient in PHENAZINE-35 is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenazine-35
A generic version of PHENAZINE-35 was approved as phendimetrazine tartrate by VIRTUS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PHENAZINE-35?
- What are the global sales for PHENAZINE-35?
- What is Average Wholesale Price for PHENAZINE-35?
Summary for PHENAZINE-35
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,019 |
| DailyMed Link: | PHENAZINE-35 at DailyMed |
Recent Clinical Trials for PHENAZINE-35
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Saudi German Hospital - Madinah | Phase 2/Phase 3 |
| M.D. Anderson Cancer Center | N/A |
US Patents and Regulatory Information for PHENAZINE-35
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abc Holding | PHENAZINE-35 | phendimetrazine tartrate | TABLET;ORAL | 085512-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
